Antibodies reacting with JCPyV_VP2 _167-15mer as a novel serological marker for JC polyomavirus infection

Abstract

Background: JC polyomavirus (JCPyV) is a widespread human polyomavirus that usually resides latently in its host, but can be reactivated under immune-compromised conditions potentially causing Progressive Multifocal Leukoencephalopathy (PML). Detection of antibodies against the major capsid protein VP1 currently is the main marker for assessment of infection with JCPyV. Methods: Based on a peptide microarray, peptide JCPyV-VP2-167-15mer was selected and a peptide ELISA was developed for detection of antibodies directed against this peptide. Epitope mapping and computational modelling was performed to further characterize this peptide. In a cohort of 204 healthy subjects it was investigated whether antibodies against JCPyV-VP2-167-15mer were correlated with VP1 serology or urinary viral load. Results: Epitope mapping of peptide JCPyV-VP2-167-15mer showed that the minimal epitope consisted of L 173 PALTSQEI 181 with amino acids P 174, L 176 and E 180 being essential for antibody recognition. Computational analysis was used to predict that this epitope is located at an exposed domain of the VP2 capsid protein, readily accessible for immune recognition upon infection. No correlation could be observed with JCPyV VP1 antibody levels, or urinary viral load. Conclusion: This work indicates that specific antibodies against JCPyV-VP2-167-15mer might be considered as a novel serological marker for infection with JCPyV.